It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: putnam6
originally posted by: squittles
originally posted by: putnam6
a reply to: infolurker
Hopefully you are right, I know nothing about this , but thier stock being down might be a negative indicator.
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$605.49down$-11.40(-1.85%)
Yeah - my guess is equal parts "hope" and "guess" - personally, I don't care if it involves eye of newt from a witches coven - as long as it works.
Remdesivir was a bit of a "tin bullet" - it plus convalescent plasma and dexamethsone for late-stage ARDS are the current standard of treatment and while it helps, it isn't a cure - far too many people are still dying (and not being counted are those whose health is permanently damaged.)
Yep we need some real good news, something tangible. As has been mentioned what ever it is will be torn apart by the media regardless. It's got to be irrefutable or it won't convince the sheep.
originally posted by: DBCowboy
So you don't care about the quality of the studies or what they actually find?
The list is a gish gallop and hydroxychloroquine is no breakthrough.
"Gish gallop" is an interesting way to describe a simple collection of studies conducted throughout the world.
Actually it appears to be an attempt to demonstrate a foregone conclusion, that HCQ is effective. What are "adjusted deaths per million", exactly? How is that figure arrived at?
The HCQtrial.com source appears to be an attempt at examining correlations between country wide HCQ use & death rates.
sciencebasedmedicine.org...
It’s not a randomized controlled trial by any stretch of the imagination
It’s an observational ecological study (sort of) prone to the ecological fallacy
Confounders are not properly controlled for, particularly mask wearing and lockdowns
It’s not peer-reviewed
Its sample size is 36, not 2.7 billion
It is not known why only 36 countries were selected, and why these 36, which reeks of cherry picking
It misreports the results of at least one study, if not several
It doesn’t actually determine how much hydroxychloroquine was actually used in the “HCQ countries” or whether and how much it was used in some of the “non-HCQ countries”
It does not define what it means by “early” versus “late” treatment
I don't think that most of those who peruse the website have examined the studies in the detail which you have. That's the idea behind a gish gallop.
This does not appear to be the case considering the vast diversity of studies listed.
originally posted by: Phage
a reply to: Heisenburg
Trump will be announcing emergency authorization for the use of convalescent plasma. Not really a breakthrough and very little to demonstrate its efficacy as yet.
FDA
originally posted by: Phage
a reply to: Heisenburg
Pick your favorite one of those studies. Let's discuss it.
Trump will be announcing emergency authorization for the use of convalescent plasma. Not really a breakthrough and very little to demonstrate its efficacy as yet.
FDA
originally posted by: Phage
a reply to: asabuvsobelow
And yet, Trump will be announcing that the FDA is granting an emergency use authorization for convalescent plasma.
Is that bad?
It's Irrelevant